Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

valsartan

Known as: N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine, (S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine, N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine 
An orally active nonpeptide triazole-derived antagonist of angiotensin (AT) II with antihypertensive properties. Valsartan selectively and… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Policy Points: Our study indicates that there are opportunities for cost savings in generic drug markets in Europe and the United… Expand
  • figure 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND It is not known whether drugs that block the renin-angiotensin system reduce the risk of diabetes and cardiovascular… Expand
  • figure 1
  • table 1
  • table 1
  • table 1
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Background Atrial fibrillation (AF) in heart failure (HF) is generally considered a negative prognostic factor. Recent studies… Expand
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Background—The role of C-reactive protein (CRP) in heart failure is not well studied. We assessed the prognostic value of CRP in… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial was designed to test the hypothesis that for the… Expand
  • table 1
  • figure 2
  • figure 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND The presence of coexisting conditions has a substantial effect on the outcome of acute myocardial infarction. Renal… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND Angiotensin-converting-enzyme (ACE) inhibitors such as captopril reduce mortality and cardiovascular morbidity among… Expand
  • table 1
  • table 1
  • figure 1
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Background—Neurohormones are considered markers of heart failure progression. We examined whether changes in brain natriuretic… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Background—Elevated urine albumin excretion (UAER) is a modifiable risk factor for renal and cardiovascular disease in type 2… Expand
  • table 1
  • table 2
  • figure 2
  • figure 1
  • table 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND Actions of angiotensin II may contribute to the progression of heart failure despite treatment with currently… Expand
Is this relevant?